Kwang-Soo Shin

Title: Kwang-Soo Shin: Innovator in Adenoviral Vector Technology

Introduction

Kwang-Soo Shin is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of adenoviral vectors. His innovative work has implications for vaccine development and cancer treatment.

Latest Patents

Kwang-Soo Shin holds a patent for an "Adenoviral vector not including replication competent adenovirus, and use thereof." This invention relates to a novel adenoviral vector that does not include a replication-competent adenovirus. The recombinant E1/E3/E4-deleted adenoviral vector, in which an antigenic protein and an E4orf6 gene are inserted in an E1 gene-deleted region, demonstrates adenovirus productivity, degree of antigen expression, neutralizing antibody production amount, and T cell induction ability similar to those of a control group. This technology can be effectively used as a carrier for various vaccines for diseases or anti-cancer vaccines. Kwang-Soo Shin has 1 patent to his name.

Career Highlights

Kwang-Soo Shin is associated with Cellid Co., Ltd., where he continues to advance his research and development efforts. His work has positioned him as a key figure in the biotechnology sector, particularly in the area of vaccine technology.

Collaborations

Some of his notable coworkers include Chang-Yuil Kang and Bongju Park. Their collaborative efforts contribute to the innovative research environment at Cellid Co., Ltd.

Conclusion

Kwang-Soo Shin's contributions to adenoviral vector technology highlight his role as an innovator in the biotechnology field. His work has the potential to impact vaccine development and cancer therapies significantly.